OCT-B201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOCT-B201
Drug Alias NameBT-201OCT-B201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOscotec Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOscotec Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A